Bone proteins costly in surgery, study says
Wall Street Journal, July 1, 2009
The use in spine surgery of bone-growth proteins has led to widespread nationwide increases in hospital charges ranging from 11% to 41% above conventional surgical costs, researchers found. The researchers studied the results of a broad U.S. sample of 328,000 spine surgeries from 2002 through 2006. The authors, from both Brigham & Women's Hospital in Boston and from Yale, also found that by 2006 the use of the new bone proteins had increased to nearly 25% of all operations in which spinal vertebrae are fused together to alleviate back pain.
- Senators Hear How Two-Midnight Rule Harms Patients, Hospitals
- 3 Management Lessons from a Supermarket Debacle
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts
- Physicians to Appeal 'Docs v. Glocks' Ruling in FL
- IOM Identifies GME Problems, Calls for Finance Changes
- Healthcare Costs Start With What We Eat
- Revenue Cycles Get a Boost from Simple JPEG Files
- Handshaking Spreads Germs. Get Over It.
- CA Fines 8 Hospitals for Medical Errors
- Hospitals Likely to Outsource ICD-10 at Launch